MDNA Life Science has appointed Chris Mitton as its CEO and Jack Riccardi as its CFO, effective immediately. Mitton has replaced former interim CEO George Steinfels, who will continue to support MDNA Life Sciences as a Board Advisor. He previously has held sales roles at Abbott and Bayer Helathcare. In addition, Mitton has held senior commercial operations leadership positions at Ipsogen, Qiagen, and Cancer Genetics. Riccardi has held CFO position in both privately held and publicly traded entities including Omni Bio Pharmaceutical, ADial Pharmaceuticals, and Modern Visuals, over the past 10 years. Prior to that, he has held strategic finance roles, including as director of strategic planning and director of finance for General Motors.